Pain control benefits HS patients

Adalimumab (Humira, AbbVie) enhances both health-related quality of life and work productivity in patients with moderate-to-severe hidradenitis suppurativa, according to the results of two phase 3 clinical trials.
Dermatology Times – Dermatology

Eczema Free Foreverâ„¢